Craig Safian
Analyst · Baird. Your line is now open
Thank you, Gene, and good morning, everyone. I hope you, your families and your colleagues are safe and healthy as we navigate the pandemic and the economic downturn. I’ll provide an update on our strong liquidity and capital structure as well as an overview of the cost actions we have taken to ensure our financial flexibility. Then I will review our first quarter results, including the impact of COVID-19. Finally, I’ll describe our updated outlook for the year within the context of the rapidly evolving macro environment. Beginning in early March, as we first started to see the impacts the pandemic could have on our business, we quickly pivoted to EBITDA preservation and cash conservation mode. Gene described many of the actions we took. The goal of all of the actions was to ensure our financial strength and ongoing flexibility. I’ll start this morning with a discussion of our cash and balance sheet position. At the end of the first quarter, we had $228 million of cash, which is more than we need to run the business. On April 1, to increase our cash position and preserve financial flexibility, we drew $300 million on our revolver, bringing our cash balance to $528 million. This puts our liquidity in a very strong position, reinforced by our ability to continue to generate positive free cash flow. We have additional revolver capacity of more than $700 million available to us as well. Cash flow trends in April continued on a positive track. Our March 31 debt balance was about $2.2 billion. That increased by $300 million to $2.5 billion after the April 1 revolver draw. We have also amended our credit facility to provide greater covenant flexibility as follows: First, our total leverage covenant has increased 0.5 turn from 4.5 to 5x. Second, our secured leverage covenant has increased by 0.25 turn from 3.5 to 3.75x. Our interest coverage covenant is unchanged. The calculations use gross debt, trailing 12-month EBITDA and trailing 12-month interest expense. Gross debt, EBITDA and interest expense used for the covenant calculations are defined in our 2016 credit agreement. Based on the debt levels after the incremental revolver draw on April 1, our leverage ratios under the covenants were 3.5x total debt, 2.4x secured debt and 7.4x interest coverage. These are all well within the required levels for compliance under our credit facility. While we don’t expect to need the incremental covenant capacity, we secured the amendment to ensure future financial flexibility. We repurchased $73 million of our stock in the first quarter. Of that total, $34 million relate to open market stock repurchases. We paused our share repurchases during the last week of February. We will not resume until we have a clearer picture of how the pandemic and economic downturn will play out. In addition to our strong cash position and access to capital, we are taking steps to align our costs with our revenue, allowing us to continue to generate positive free cash flow. Going into the current situation, we’d already built a plan for 2020 that aligns cost growth with revenue growth. Following the rapid changes in the world as a result of COVID-19, we took additional steps to ensure our long-term financial health and operational excellence through a number of cost-avoidance initiatives. We made tough decisions to eliminate merit increases, freeze hiring temporarily, restrict travel, cancel internal meetings and reduce third-party spending. We have also made reductions to our Conferences staff to better align our cost structure with our Conferences revenue and new schedule. These decisive actions help ensure our ongoing financial flexibility in this challenging and uncertain environment without compromising on the quality of the insight, advice and service we provide to our clients. We remain well positioned to reaccelerate and drive future growth once the timing of the economic recovery in this pandemic becomes more evident. Moving to our first quarter results. Research and Consulting growth were in line with our expectations, and we moved quickly to manage costs late in the quarter. First quarter revenue was $1 billion, up 5% as reported and up 6% on an FX-neutral basis. Excluding Conferences, our revenues were up 11% year-over-year on an FX-neutral basis. In addition, contribution margin was 66%, up 200 basis points versus the prior year. EBITDA was $214 million, up 51% year-over-year and 53% FX neutral. Our EBITDA performance was tracking strongly through February and then benefited from the cost-avoidance initiatives we implemented in March. Adjusted EPS was $1.20, and free cash flow in the quarter was $31 million. Research revenue in the first quarter grew 10% year-over-year on a reported basis and 11% on an FX-neutral basis. First quarter contribution margin was 72%, as margins benefited from temporary cost-avoidance initiatives, which we will only keep in place while the macro environment remains challenging. Total contract value was $3.5 billion at March 31, FX-neutral growth of 11% versus the prior year. As we do each year, we have updated our historical research metrics at 2020 FX rates in our earnings supplement. Global Technology Sales contract value at the end of the first quarter was $2.8 billion, up 11% versus the prior year. GTS CV growth and associated metrics performed well in January and February, before slowing late in the quarter as the COVID-19 response led to lower new business growth and modestly lower retention rates. The more challenging selling environment had an impact on most of our reported metrics. Client retention for GTS remains at around 82%, down about 50 basis points year-over-year. Wallet retention for GTS was 104% for the quarter, down about 200 basis points year-over-year. GTS new business declined 2% versus last year. We ended the first quarter with 12,826 GTS enterprises, slightly up from last year. The average contract value per enterprise continues to grow. It now stands at $219,000 for enterprise in GTS, up 11% year-over-year. Growth in CV per enterprise reflects the combination of upsell, increased number of subscriptions and price. At the end of the first quarter, we had 3,196 quota-bearing associates in GTS or an increase of 5% year-over-year. As part of our cost reduction programs we announced in late March, we temporarily froze headcount growth. For GTS, the year-over-year net contract value increase, or NCVI, divided by the beginning period quota-bearing headcount, was $92,000 per salesperson, down 21% versus the first quarter of last year. As we get more clarity on the economy and the short-term demand environment, we will look to increase sales hiring to position us for sustained long-term double-digit growth on the top and bottom line. Global Business Sales contract value was $646 million at the end of the first quarter. That’s about 20% of our total contract value. CV growth was 8% year-over-year, both reported and organic. GxL CV grew 48% to $307 million, and legacy CV declined 13% year-over-year to $338 million. Total GBS new business was down 12% in the quarter, impacted largely by supply chain and marketing. Our supply chain practice saw a decrease in both retention and new business. The supply chain practice was uniquely affected in the quarter by the global disruptions caused by the pandemic developments in Asia. Last quarter, we explained that we’ve stopped selling and renewing some lower-margin marketing products. As expected, this impacted GBS growth. The GxL legacy split in GBS becomes less meaningful every quarter, so we are phasing out reporting GBS that way. This quarter, we are providing the new business and attrition dollars for GxL and legacy as we did in 2019. In the first quarter, total GxL new business was $22 million, while legacy new business was $5 million. Also in the first quarter, GxL attrition was $17 million and legacy attrition was $14 million. Client retention for GBS was 83%, up about 170 basis points year-over-year. Wallet retention for GBS was 101% for the quarter, up about 700 basis points year-over-year. We ended the first quarter with 5,025 GBS enterprises, down about 4% from last year. The average contract value per enterprise continues to grow. It now stands at $128,000 per enterprise in GBS, up 13% year-over-year. Growth in CV per enterprise reflects upsell, an increased number of subscriptions and price. At the end of the first quarter, we had 862 quota-bearing associates in GBS, down 1% year-over-year. Headcount was down sequentially and year-over-year as we optimized our territories and then temporarily froze hiring as part of our cost-avoidance program. For GBS, the year-over-year net contract value increase, or NCVI, divided by the beginning period quota-bearing headcount was $57,000 per salesperson, a significant improvement from when it was negative last year. As we communicated in March, the Conferences segment has been materially impacted by the global response to the pandemic. We were able to hold a few small conferences early in the first quarter, resulting in $14 million of revenue. We will not have any conferences through August. For the rest of the year, we have revised the schedule for in-person conferences. The result is a plan for fewer conferences with a focus on maximizing the value we deliver for our clients. I’ll review some additional points related to Conferences in the guidance section a bit later. First quarter Consulting revenues increased by 3% year-over-year to $96 million. FX-neutral growth was 4%. Consulting contribution margin was 31% in the first quarter, down 14 basis points versus the prior year quarter. Labor-based revenues were $81 million, up 3% versus Q1 of last year or 4% on an FX-neutral basis. Labor-based billable headcount of 808 was up 9%. Utilization was 62%. Backlog at March 31 was $110 million, up 1% year-over-year on an FX-neutral basis. Our backlog provides us with about 4.5 months of forward revenue coverage, in line with our operating target. Contract Optimization revenues were up 1% on a reported basis versus the prior year quarter against the difficult compare. As we have detailed in the past, this part of the Consulting segment is highly variable. SG&A decreased 4% year-over-year in the first quarter and 3% on an FX-neutral basis as the cost-avoidance initiatives we put in place, specifically around internal meetings and other travel, went into effect. EBITDA for the first quarter was $214 million, up 51% year-over-year on a reported basis and up 53% on an FX-neutral basis. Depreciation in the quarter was up approximately $3 million from last year as additional office space went into service. Amortization was flat sequentially. Net interest expense, excluding deferred financing costs in the quarter, was $25 million, up from $23 million in the first quarter of 2019. Net interest expense is up due to higher floating to fixed hedge costs as we rolled previous contracts forward. The Q1 adjusted tax rate, which we used for the calculation of adjusted net income, was 22.5% for the quarter, roughly in line with our guided full year rate. The tax rate for the items used to adjust net income was also 22.5% in the quarter. We completed an intercompany sale of an intellectual property in April 2020. We expect it will have a material favorable tax impact to our second quarter 2020 financial results. This benefit was already reflected in our full year guidance. Adjusted EPS in Q1 was $1.20. We have updated the definition we use for free cash flow to be: cash provided by operating activities, less capital expenditures, and we will no longer be adding back adjustments or non-recurring items. This free cash flow definition provides a measure that reflects cash available for capital allocation like debt repayment. Operating cash flow for the quarter was $56 million compared to $36 million last year. The increase in operating cash flow was primarily driven by cost-avoidance initiatives and improved collections. CapEx for the quarter was $25 million. This includes a small software techquisition that helps increase analyst productivity through automation and AI. Excluding the small acquisition, CapEx would have been down versus the prior year quarter. Free cash flow for the quarter was $31 million, which is up 101% versus the prior year. This includes outflows of about $10 million of acquisition, integration and other non-recurring items. Free cash flow as a percent of revenue or free cash flow margin was 10% on a rolling four-quarter basis, continuing the improvement we’ve been making over the past few years. Free cash flow as a percent of GAAP net income was about 150%, almost back to historical levels. Since there is significantly more uncertainty and volatility in the economy than normal, we are providing an updated outlook for 2020. Before I go through the outlook assumptions for each segment, I’ll start with the overall approach we have taken to developing the updated outlook for 2020. First, we’ve taken our experience and results from March and April to drive forecast for the balance of the year. Second, we have not forecast a recovery for 2020. Third, our overall outlook assumes that we will not be able to run conferences for the balance of the year. We do have plans in place to start delivering conferences again in September if that proves possible. And fourth, we are calibrating our cost reduction programs with our top line results. If business is weaker than forecast, we will further reduce costs to protect EBITDA dollars and cash flow. And if business is stronger than forecast, we will reinstate certain expenses that we had turned off to protect profitability. With the strengthening of the U.S. dollar, we are giving the updated guidance in reported dollar terms, and making no assumptions on future changes or volatility to exchange rates. We now forecast reported Research revenue of at least $3.425 billion for the full year, about 1% to 2% growth. This reflects a continuation of late March and April new business and retention trend through the rest of the year. We expect total CV to decelerate from the first quarter due to a more challenging customer spending and decision-making environment. Based on what we are seeing in March and April and improvements we have made in the business over the past decade, CV growth should remain above the levels we saw in the last downturn. CV changes earlier in the year have a larger impact to full year Research revenue growth. There is a lag effect on Research revenue. So slower CV growth this year may lead to slower Research revenue growth in 2021. As we ramp back up our spending to position ourselves for long-term success, there may be a short-term headwind to margins due to the lag between CV and revenue growth. For the Conferences segment, as I mentioned, we are currently planning to resume conferences in September. However, our guidance is based on not being able to run any conferences for the duration of 2020. The result, without running conferences for the balance of the year, will be revenue of about $35 million. We will continue to incur costs in the Conferences business, both cost of services as well as SG&A. Within the business, we have direct expenses that relate to specific conferences and other expenses that don’t. We won’t be incurring the direct costs related to specific conferences that are canceled. This results in modestly lower cost and lower decremental margins than we had expected when we provided an update in late March. Wherever possible, we expect to roll forward conference participation by exhibitors and attendees to future conferences. If we are able to run our updated conference calendar in the last four months of the year, we estimate additional revenue of approximately $200 million. In addition, at the end of April, we reduced the number of associates in conferences to align with the new reality of the business for 2020. Severance costs of $5 million to $6 million will be incurred in the second quarter. Finally, we have the potential to recover insurance for canceled events beyond the amount of the direct expenses, potentially up to the amount of the lost revenue in some cases. The timing of insurance recovery remains uncertain, but our policies are specific to our Conferences business, and not generic business interruption coverage. The insurance recovery will not be included in EBITDA and is not included in our EBITDA guidance. However, for debt covenant purposes, the insurance recovery is included in the calculation of EBITDA. We continue to work with our insurance brokers and providers and will provide updates on our progress in the future quarters. We now expect reported Consulting revenue of at least $350 million, or a decline of about 11% for the full year. The Consulting outlook contemplates a slowdown in labor-based demand and reflects very challenging compares for the Contract Optimization business through most of the year, and implies being down roughly 15% for the remainder of 2020. Overall, we expect consolidated revenue of at least $3.81 billion. That’s a reported decline of about 10% versus 2019. For the full year, at current FX rates and business mix, we expect a drag on revenue growth of about 130 basis points. Cost-avoidance programs could yield up to $400 million in savings for the full year, assuming no recovery from the economic downturn. The implied operating costs are not a new run rate, but reflect planning assumptions for a cautious view of the revenue outlook. As soon as we can get back to a normal operating environment, we will resume spending to drive future growth. We expect adjusted EBITDA of at least $625 million. That’s despite a revenue impact we currently contemplate of about $800 million, and a roughly $20 million negative impact from FX to EBITDA. If our top line forecast proves conservative, and we are able to restore more normal spending, we continue to expect margins to be at least 16.1%, which will be flat to 2019. We expect an adjusted tax rate of around 22% for 2020. We expect 2020 adjusted EPS of at least $3. For 2020, we expect free cash flow of at least $300 million. Our free cash flow guidance reflects both the P&L outlook we just discussed as well as some slowing of collections. All the details of our full year guidance are included on our Investor Relations site. Finally, for the second quarter of 2020, we expect adjusted EBITDA of about $160 million to $165 million. In closing, we are focused on the right things we need to do for our associates, clients and shareholders to deliver long-term value. As Gene discussed, we will execute to come out of the downturn better positioned than before to drive long-term sustained double-digit growth. We know that the value of Gartner is the long-term stream of free cash flows we expect to generate by delivering value to our clients in a very large addressable global market. So while we are taking the steps to ensure our short-term financial flexibility, we remain focused on driving long-term shareholder value. Amid a tough economic backdrop, our Research business had a healthy quarter and Consulting held up as well. We are avoiding expenses, managing cash flow and working through insurance recovery. We maintain a strong and healthy balance sheet, and are focused on maintaining high levels of liquidity and financial flexibility. With that, I’ll turn the call back over to the operator, and we’ll be happy to take your questions. Operator?